Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
A placebo-controlled superiority design was used to evaluate the efficacy of 60-120 mg/ day of Buagafuran capsules in the treatment of GAD.
Epistemonikos ID: f432dcd37fdb1bd6a250b2bd6b594f93d2e3f568
First added on: May 15, 2024